SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-032213
Filing Date
2019-08-15
Accepted
2019-08-14 20:58:05
Documents
6
Effectiveness Date
2019-08-15

Document Format Files

Seq Description Document Type Size
1 S-8 onct-s8.htm S-8 197417
2 EX-5.1 onct-ex51_9.htm EX-5.1 18127
3 EX-10.1 onct-ex101_10.htm EX-10.1 163572
4 EX-10.2 onct-ex102_8.htm EX-10.2 47776
5 EX-23.1 onct-ex231_7.htm EX-23.1 4184
6 EX-23.2 onct-ex232_6.htm EX-23.2 3012
  Complete submission text file 0001564590-19-032213.txt   435199
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233288 | Film No.: 191028246
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1